Copper status and its relation to abdominal obesity indices and liver function in non-alcoholic fatty liver disease: a case-control study.

Low dietary copper intake is linked to an increased risk of non-alcoholic fatty liver disease (NAFLD). While researchers have long suspected that micronutrient deficiencies contribute to metabolic dysfunction, the role of copper has remained inconsistent in clinical literature. A new case-control study from researchers at Tabriz University of Medical Sciences suggests that even when blood copper levels appear normal, the actual amount of copper consumed through diet may serve as a critical predictor for liver disease.

The disconnect between diet and blood markers

Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by excessive fat accumulation in the liver. This occurs in the absence of alcohol or drug abuse. It is a massive global health burden. It affects approximately one billion people worldwide. The disease serves as a primary driver of cirrhosis (severe scarring of the liver) and liver cancer.

The disease typically follows a "multi-hit" process. An initial metabolic insult, such as insulin resistance (a condition where cells do not respond properly to insulin), occurs first. This is followed by a "second hit" of oxidative stress. This involves the accumulation of reactive oxygen species (ROS), which are unstable molecules that can damage cellular structures.

Copper (Cu) is an essential trace mineral. It acts as a vital cofactor (a non-protein chemical compound required for an enzyme's activity) for enzymes involved in redox reactions (chemical processes involving the transfer of electrons). Specifically, copper is a structural component of superoxide dismutase (SOD). This enzyme helps detoxify ROS. Because of this role, scientists have hypothesized that copper inadequacy might exacerbate the oxidative stress that drives NAFLD progression.

However, the existing literature is inconsistent. Some studies suggest low serum copper is linked to fat accumulation. Other studies find no connection at all. The central problem is that measuring copper in the blood (serum) may not accurately reflect the actual dietary intake. It may also fail to reflect the functional status of the mineral within the liver.

Mapping the copper-NAFLD relationship

To untangle this, the authors conducted a case-control study involving 160 adults in Iran. Participants were aged 20–60. The researchers recruited 80 patients with mild or moderate NAFLD, confirmed via ultrasonography (an imaging technique using sound waves). They matched these patients with 80 healthy controls. The groups shared similar ages, sexes, and Body Mass Indices (BMI).

The study employed a dual-track methodology to capture both the biological and behavioral sides of the equation:

1. Biochemical Assessment: The researchers collected fasting blood samples. They measured serum levels of copper, ceruloplasmin (a protein that carries copper in the blood), ferritin (a marker of iron stores), and liver enzymes like alanine aminotransferase (ALT) and aspartate aminotransferase (AST). These enzymes are released into the bloodstream when liver cells are damaged. They act as indicators of liver injury.
2. Dietary Reconstruction: The team used a validated 168-item semi-quantitative food frequency questionnaire (FFQ). This tool asks participants about their consumption of copper-rich foods. Examples include organ meats, seafood, legumes, and nuts. This allowed the team to estimate daily intake over the past year.

By comparing these two tracks, the authors sought to determine if the "biological signal" in the blood matched the "behavioral signal" of the diet.

Dietary intake as a primary predictor

The results reveal a divergence between blood markers and dietary habits. The paper finds that serum levels of copper and ceruloplasmin did not differ significantly between the NAFLD group and the healthy controls. Consequently, a standard blood panel might miss an underlying nutritional deficit.

However, the dietary data provided a different perspective. The authors report that low dietary copper intake (specifically $<0.95$ mg/day) was a potent predictor of the disease. After adjusting for confounding factors (variables that can distort the relationship between a cause and an effect) like BMI and waist circumference, the study found a significant association. Low copper intake was associated with a nearly sixfold increase in the odds of having NAFLD (OR = 5.82; 95% CI: 1.55, 21.85; $p = 0.009$). This means the risk is substantially higher for those consuming less than the threshold.

Furthermore, the researchers observed specific correlations that only appeared in the NAFLD group. In these patients, both serum and dietary copper levels were positively correlated with abdominal obesity indices. These included waist circumference (WC) and waist-to-height ratio (WHtR). This suggests that as obesity markers increase, the relationship with copper status becomes more complex in patients with liver disease.

Limits of the current evidence

While the link between diet and disease is compelling, the study has notable boundaries. First, the case-control design is observational. The authors note that this format can identify associations. However, it cannot prove that low copper intake causes NAFLD. It is possible that metabolic changes in NAFLD alter how the body processes copper.

Second, the findings are based on a specific population in Iran. The authors note that dietary patterns here may differ from Western diets. Traditional Iranian diets include copper-rich foods. This may explain the relatively low proportion of severe copper deficiency in this cohort. Therefore, these results may not generalize to all global populations.

Finally, the study does not explore the synergistic effects (where two substances work together to produce a greater effect) between copper and other micronutrients. Factors like zinc or fructose intake also influence copper homeostasis (the process by which the body maintains constant levels of a substance). For a practitioner, this means copper is likely part of a much larger, interconnected nutritional web.

The verdict: A reason to look beyond the blood panel

Is dietary copper a viable target for NAFLD prevention? Based on this study, the answer is likely yes, but with a caveat. We cannot rely on standard serum tests to detect the deficiency.

The paper provides evidence that dietary insufficiency is a meaningful risk factor. This holds true even when blood biomarkers remain stable. For clinicians, the takeaway is that a "normal" copper reading in a blood test might mask a dietary deficit. Such a deficit could contribute to liver stress. For researchers, the next step is moving from correlation to causation. Future work must investigate how low copper levels modulate the inflammatory processes in the liver. Until then, copper intake remains a critical piece of the metabolic puzzle.

Figures from the paper